| 摘要 |
<p>The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, V, W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPTl and can be used as medicaments.</p> |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;ACKERMANN, JEAN;BLEICHER, KONRAD;CECCARELLI, SIMONA, M.;CHOMIENNE, ODILE;MATTEI, PATRIZIO;OBST SANDER, ULRIKE |
发明人 |
ACKERMANN, JEAN;BLEICHER, KONRAD;CECCARELLI, SIMONA, M.;CHOMIENNE, ODILE;MATTEI, PATRIZIO;OBST SANDER, ULRIKE |
